Roche to Pay Nurix Up to $2.3 Billion for Experimental Cancer Drug Rights
Roche Holding AG agreed to pay Nurix Therapeutics Inc. as much as $2.3 billion for rights to an…
Further Basel delays expected as UK and EU wait on Trump
More changes and delays to Basel III capital rules for banks are anticipated in both the UK and…
Zurich’s EFG Targets Latin American Wealth in South Florida, Brazil Expansion
EFG International AG, a private-banking boutique based in Zurich, is expanding its 300-person team serving clients from the…
UBS Eyes Americas Deals As New Governance Framework Shapes Capital Choices
Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million…
UBS Sees Recovery Signs in US Wealth Business as Inflows Return
UBS Group AG’s wealth-management business in the Americas showed tentative signs of revival after a period of client…
Roche Falls as Side Effects Data for Obesity Drug Raises Concern
Shares of Roche Holding AG fell after a poster highlighted side effects in an early-stage study of the…
Roche Pursues Muscle-Growth Research in Obesity as Neuromuscular Work Ends
Roche Holding AG said it plans to keep studying an experimental compound for its muscle-growth potential during weight…
Roche Hires Novo Executive to Help Push Into Obesity Drug Market
Roche Holding AG hired a senior executive from rival Novo Nordisk A/S as the Swiss drugmaker prepares to…
Oil Market ‘Singularly Focused’ on Hormuz, Vitol’s Marshall Says
Oil markets are currently pricing in the reopening of the Strait of Hormuz sooner rather than later, according…